{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:59:05Z","timestamp":1781045945994,"version":"3.54.1"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"06","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geburtshilfe Frauenheilkd"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>RSV is the leading cause of lower respiratory tract infections (LRTI) in infants. Since 2024, STIKO recommends immunising all neonates with nirsevimab prior to or during their first RSV season. This study aims to assess parental acceptance and uptake of RSV immunisation during the first implementation season in Germany.<\/jats:p>\n                  <jats:p>All neonates born at our hospital between 11 November 2024 and 31 January 2025 were included in this study. Parents received an antenatal information leaflet; counselling was part of the U2 medical checkup. The immunisation rate was assessed using data from electronic medical records. In addition, an online questionnaire surveyed parental satisfaction with the information provided.<\/jats:p>\n                  <jats:p>Of 1030 neonates, 76% received nirsevimab, 6% were protected by maternal RSVpreF vaccination (overall immunisation rate: 82%). Children of multiparous mothers were immunised less often than children of primiparous mothers (OR\u00a0=\u00a00.52; p\u00a0&lt;\u00a00.001). Mothers aged \u2265\u00a030 years were more likely to consent to vaccination (30\u201334: OR\u00a0=\u00a01.75; \u2265\u00a035: OR\u00a0=\u00a01.72). 68% of parents had already made their decision prior to delivery. Of 153 respondents, 17% requested more detailed information on safety, duration of vaccination protection, and availability of the vaccine.<\/jats:p>\n                  <jats:p>Maternal age and parity appear to be associated with nirsevimab uptake. Early prepartum counselling and transparent communications regarding product safety could further increase acceptance.<\/jats:p>","DOI":"10.1055\/a-2776-6900","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:44:26Z","timestamp":1770335066000},"page":"554-562","source":"Crossref","is-referenced-by-count":0,"title":["RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in Germany"],"prefix":"10.1055","volume":"86","clinical-trial-number":[{"clinical-trial-number":"drks00035342","registry":"10.18810\/drks"}],"author":[{"given":"Esther S.","family":"Schouten","sequence":"first","affiliation":[{"name":"Dr. von Hauner Children\u2019s Hospital, LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Division of Neonatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5046-3807","authenticated-orcid":false,"given":"Annika S.","family":"Kraft","sequence":"first","affiliation":[{"name":"Dr. von Hauner Children\u2019s Hospital, LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Division of Neonatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Delius","sequence":"additional","affiliation":[{"name":"LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ellenbach","sequence":"additional","affiliation":[{"name":"LMU Munich, BY, Germany","place":["Munich"],"department":["Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas W.","family":"Flemmer","sequence":"additional","affiliation":[{"name":"Dr. von Hauner Children\u2019s Hospital, LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Division of Neonatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hertlein","sequence":"additional","affiliation":[{"name":"LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Kehl","sequence":"additional","affiliation":[{"name":"LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[{"name":"LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Starrach","sequence":"additional","affiliation":[{"name":"LMU University Hospital, LMU Munich, BY, Germany","place":["Munich"],"department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","article-title":"Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999","volume":"21","author":"S Leader","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/s0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Y Li","year":"2022","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/infdis\/jiac137","article-title":"Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged \u2264\u00a05 Years (INSPIRE Study)","volume":"226","author":"K Hartmann","year":"2022","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"CB Hall","year":"2013","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/nejmoa2110275","article-title":"Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants","volume":"386","author":"LL Hammitt","year":"2022","journal-title":"N Eng J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants","volume":"389","author":"SB Drysdale","year":"2023","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJMoa2314885","article-title":"Nirsevimab and Hospitalization for RSV Bronchiolitis","volume":"391","author":"Z Assad","year":"2024","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069510","article-title":"Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants","author":"A Hsiao","year":"2025","journal-title":"Pediatrics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(25)00093-8","article-title":"Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis","author":"DM Sumsuzzman","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants","volume":"388","author":"B Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.53696","article-title":"Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024","volume":"8","author":"KB Jacobson","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.60729","article-title":"Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season","volume":"8","author":"EA Litman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126674","article-title":"RSV immunization uptake among infants and pregnant persons \u2013 Wisconsin, October 1, 2023-March 31, 2024","volume":"47","author":"M Kemp","year":"2025","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102986","article-title":"Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in France","volume":"79","author":"C Ocana de Sentuary","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103281","article-title":"Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis","volume":"84","author":"D Trusinska","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2024.29.4.2400033","article-title":"Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023\/24 season in Luxembourg","volume":"29","author":"C Ernst","year":"2024","journal-title":"Euro Surveill"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12050549","article-title":"Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d\u2019Aosta Region, Italy, in the 2023\u20132024 Epidemic Season","volume":"12","author":"A Consolati","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109543118","article-title":"Incentives can spur COVID-19 vaccination uptake","volume":"118","author":"H Kl\u00fcver","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV Prefusion F Protein-Based Maternal Vaccine \u2013 Preterm Birth and Other Outcomes","volume":"390","author":"I Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1542\/hpeds.2024-007986","article-title":"Factors Associated With Nirsevimab Uptake in Healthy Newborns","volume":"14","author":"E Aragona","year":"2024","journal-title":"Hosp Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126541","article-title":"Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands","volume":"44","author":"LM Harteveld","year":"2025","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41372-025-02282-5","article-title":"Navigating parental hesitancy in public health: the case for RSV immunization in newborns","volume":"45","author":"MK Baumgartner","year":"2025","journal-title":"J Perinatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2341505","article-title":"Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody","volume":"20","author":"B Treston","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067532","article-title":"Parent Perspectives on Nirsevimab for Their Newborn","volume":"154","author":"S Hinderstein","year":"2024","journal-title":"Pediatrics"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.018","article-title":"Parental knowledge and attitudes to infant immunization in the context of RSV: All about confidence?","volume":"42","author":"S Langer","year":"2024","journal-title":"Vaccine"}],"container-title":["Geburtshilfe und Frauenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2776-6900.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:30:40Z","timestamp":1781044240000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2776-6900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":25,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2776-6900","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0016-5751","1438-8804"],"issn-type":[{"value":"0016-5751","type":"print"},{"value":"1438-8804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}